Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Treatment of Mild-moderate Clostridium Difficile Infection (CDI)
- First Posted Date
- 2019-10-09
- Last Posted Date
- 2022-12-16
- Lead Sponsor
- ImmuniMed Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT04121169
- Locations
- 🇨🇦
Foothills Medical Center, Calgary, Alberta, Canada
News
No news found